Lifecore Biomedical, Inc.
Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a contract development and manufacturing organization serving pharmaceutical, biotechnology and medical-device companies. It develops, manufactures and aseptically fills complex formulations and highly viscous sterile injectable drugs and device products in syringes, vials… From the company’s description.
In fiscal 2024, Lifecore Biomedical, Inc. reported revenue of $128.87M, up 0.5% from fiscal 2023, and a net loss of $38.72M. Its operating margin was −13.4%, and operations used $0.21M in cash.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure.
What Lifecore Biomedical, Inc. does
In the company’s own words
Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a contract development and manufacturing organization serving pharmaceutical, biotechnology and medical-device companies. It develops, manufactures and aseptically fills complex formulations and highly viscous sterile injectable drugs and device products in syringes, vials and cartridges, supporting programs from analytical and formulation development through clinical production, scale-up and commercial manufacturing. Lifecore is a U.S. manufacturer of non-animal-sourced hyaluronic acid (HA), produced by bacterial fermentation, and supplies it in bulk and in formulated injectable products used in areas including ophthalmology and orthopedics; it also handles non-HA sterile injectables. The company operates as one integrated reportable segment and provides services ranging from HA raw materials and development to finished-product manufacturing and supply-chain support. Its business traces back to diagnostic devices in the 1960s and HA capabilities developed in the early 1980s; since 2023 it has operated as a standalone CDMO after divesting its food businesses. In fiscal 2025, Lifecore reported revenue of $[?] and had 406 employees as of May 25, 2025. Its website is www.lifecore.com.
Company details
- Sector
- Consumer Staples
- Industry (SIC)
- Pharmaceutical Preparations
- Headquarters
- CHASKA, MN
- Fiscal year end
- May
- CIK
- 1005286
- SIC
- 2834
Financial performance, year by year
Fiscal 2011–2024 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Lifecore Biomedical, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Lifecore Biomedical, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Lifecore Biomedical, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Lifecore Biomedical, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Lifecore Biomedical, Inc.'s last four quarterly filings that the numbers alone won't show?”